{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:22:52Z","timestamp":1790097772619,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s40262-024-01397-w","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T10:03:28Z","timestamp":1722852208000},"page":"1167-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus \u201cExpanded Haemodialysis\u201d"],"prefix":"10.1007","volume":"63","author":[{"given":"Fiorenza","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Milla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-6118","authenticated-orcid":false,"given":"Christian","family":"Zanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Tesauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslava","family":"Longhitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"De Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Abbruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lassola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Samoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Brendolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Scaravilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Arpicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"1397_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","volume":"39","author":"O Joannes-Boyau","year":"2013","unstructured":"Joannes-Boyau O, Honor\u00e9 PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med. 2013;39:1535\u201346.","journal-title":"Intensive Care Med"},{"key":"1397_CR2","doi-asserted-by":"publisher","DOI":"10.1086\/444500","author":"RL Trotman","year":"2005","unstructured":"Trotman RL, Williamson JC, Shoemaker DM, Salzer WL. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. Clin Infect Dis. 2005. https:\/\/doi.org\/10.1086\/444500.","journal-title":"Clin Infect Dis"},{"key":"1397_CR3","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2001.450802.x","author":"JF Bugge","year":"2001","unstructured":"Bugge JF. Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand. 2001. https:\/\/doi.org\/10.1034\/j.1399-6576.2001.450802.x.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1397_CR4","doi-asserted-by":"publisher","unstructured":"Ferrari F, Sartori M, Milla P. Antibiotic adjustment in continuous renal replacement therapy. In: Critical care nephrology: third edition. 2019. https:\/\/doi.org\/10.1016\/B978-0-323-44942-7.00175-8.","DOI":"10.1016\/B978-0-323-44942-7.00175-8"},{"key":"1397_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/0310057x0203000203","author":"M Pinder","year":"2002","unstructured":"Pinder M, Bellomo R, Lipman J. Pharmacological principles of antibiotic prescription in the critically III. Anaesth Intensive Care. 2002. https:\/\/doi.org\/10.1177\/0310057x0203000203.","journal-title":"Anaesth Intensive Care"},{"key":"1397_CR6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2371","author":"M Ulldemolins","year":"2011","unstructured":"Ulldemolins M, Roberts JA, Lipman J, Rello J. Antibiotic dosing in multiple organ dysfunction syndrome. Chest. 2011. https:\/\/doi.org\/10.1378\/chest.10-2371.","journal-title":"Chest"},{"key":"1397_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-013-3088-4","author":"AA Udy","year":"2013","unstructured":"Udy AA, Roberts JA, Lipman J. Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med. 2013. https:\/\/doi.org\/10.1007\/s00134-013-3088-4.","journal-title":"Intensive Care Med"},{"key":"1397_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41581-018-0002-x","volume":"14","author":"C Ronco","year":"2018","unstructured":"Ronco C, Clark WR. Haemodialysis membranes. Nat Rev Nephrol. 2018;14:394\u2013410.","journal-title":"Nat Rev Nephrol"},{"key":"1397_CR9","doi-asserted-by":"publisher","DOI":"10.1159\/000489082","author":"S Balgobin","year":"2018","unstructured":"Balgobin S, Morena M, Brunot V, et al. Continuous veno-venous high cut-off hemodialysis compared to continuous veno-venous hemodiafiltration in intensive care unit acute kidney injury patients. Blood Purif. 2018. https:\/\/doi.org\/10.1159\/000489082.","journal-title":"Blood Purif"},{"key":"1397_CR10","doi-asserted-by":"publisher","DOI":"10.1159\/000342631","author":"JJ Schmidt","year":"2013","unstructured":"Schmidt JJ, Hafer C, Clajus C, Hadem J, Beutel G, Schmidt BMW, Kielstein JT. New high-cutoff dialyzer allows improved middle molecule clearance without an increase in albumin loss: a clinical crossover comparison in extended dialysis. Blood Purif. 2013. https:\/\/doi.org\/10.1159\/000342631.","journal-title":"Blood Purif"},{"key":"1397_CR11","doi-asserted-by":"publisher","DOI":"10.1159\/000522321","author":"F Ferrari","year":"2022","unstructured":"Ferrari F, Husain-Syed F, Milla P, et al. Clinical assessment of continuous hemodialysis with the medium Cutoff EMiC\u00ae 2 membrane in patients with septic shock. Blood Purif. 2022. https:\/\/doi.org\/10.1159\/000522321.","journal-title":"Blood Purif"},{"key":"1397_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Outcomes(KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes(KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2:1\u2013138.","journal-title":"Kidney Int"},{"key":"1397_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304\u201377.","journal-title":"Intensive Care Med"},{"key":"1397_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/14787210.2017.1338139","volume":"15","author":"IK Delattre","year":"2017","unstructured":"Delattre IK, Taccone FS, Jacobs F, Hites M, Dugernier T, Spapen H, Laterre P-F, Wallemacq PE, Van Bambeke F, Tulkens PM. Optimizing \u03b2-lactams treatment in critically-ill patients using pharmacokinetics\/pharmacodynamics targets: are first conventional doses effective? Expert Rev Anti Infect Ther. 2017;15:677\u201388.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1397_CR15","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint tables for interpretation of MICs and zone diameters. Version 13.1. https:\/\/www.eucast.org\/clinical_breakpoints. Accessed 9 Mar 2024."},{"key":"1397_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/jcpt.13657","volume":"47","author":"DJ Selig","year":"2022","unstructured":"Selig DJ, DeLuca JP, Chung KK, Pruskowski KA, Livezey JR, Nadeau RJ, Por ED, Akers KS. Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis. J Clin Pharm Ther. 2022;47:1091\u2013102.","journal-title":"J Clin Pharm Ther"},{"key":"1397_CR17","unstructured":"FDA FDA Approved Drug Products: ZOSYN (piperacillin and tazobactam) injection."},{"key":"1397_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2020.122151","author":"P Milla","year":"2020","unstructured":"Milla P, Ferrari F, Muntoni E, Sartori M, Ronco C, Arpicco S. Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2020. https:\/\/doi.org\/10.1016\/j.jchromb.2020.122151.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1397_CR19","first-page":"1","volume-title":"Critical care toxicology","author":"MJ Cormier","year":"2016","unstructured":"Cormier MJ, Ghannoum M. Extracorporeal substance removal. In: Critical care toxicology. Cham: Springer International Publishing; 2016. p. 1\u201312."},{"key":"1397_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215823","volume":"14","author":"L Weidhase","year":"2019","unstructured":"Weidhase L, Haussig E, Haussig S, Kaiser T, de Fallois J, Petros S. Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: a prospective randomized controlled trial. PLoS ONE. 2019;14: e0215823.","journal-title":"PLoS ONE"},{"key":"1397_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/ndt\/gfr480","volume":"27","author":"WD Lyndon","year":"2012","unstructured":"Lyndon WD, Wille KM, Tolwani AJ. Solute clearance in CRRT: prescribed dose versus actual delivered dose. Nephrol Dial Transplant. 2012;27:952\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"1397_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1489-9","author":"M Neri","year":"2016","unstructured":"Neri M, Villa G, Garzotto F, et al. Nomenclature for renal replacement therapy in acute kidney injury: Basic principles. Crit Care. 2016. https:\/\/doi.org\/10.1186\/s13054-016-1489-9.","journal-title":"Crit Care"},{"key":"1397_CR23","unstructured":"Dodero N BPMR. Elementi di matematica, 2nd ed. 1996."},{"issue":"4","key":"1397_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2174\/1574887115666200811105251","volume":"15","author":"Y Longhitano","year":"2020","unstructured":"Longhitano Y, Zanza C, Thangathurai D, Taurone S, Kozel D, Racca F, et al. Gut alterations in septic patients: a biochemical literature review. Rev Recent Clin Trials. 2020;15(4):289\u201397. https:\/\/doi.org\/10.2174\/1574887115666200811105251.","journal-title":"Rev Recent Clin Trials"},{"key":"1397_CR25","unstructured":"Ferrari Fiorenza SMMP. Antibiotic adjustment in continuous renal replacement therapy, 3rd ed. 2018."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-024-01397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-024-01397-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-024-01397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:10:10Z","timestamp":1724454610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-024-01397-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1007\/s40262-024-01397-w","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"19 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to the principles of the Declaration of Helsinki and approved by the Ethics Committees of San Bortolo Hospital of Vicenza (n. 46\/15A and amendment n. 36\/16A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}},{"value":"Patients and\/or legal representatives gave written consent to participating in the study and for their anonymous data to be included in publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Publication policy is included in the study protocol, which has obtained the Ethical Committee approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets used and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"NA.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"C.R. is a consultant of Astute Medical, OCD, Asahi Medical, Baxter, Toray Medical. None of the other authors has a financial interest related to this study to disclose. All other authors declare no conflicts of interest.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was partially supported by an independent research grant from Fresenius Medical Care. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The protocol was developed by F.F. and M.S. F.F., A.B., M.Z. and C.R. also oversaw the project. M.Z. and M.S. generated the random allocation sequence. M.S., S.S., S.L. A.B. and S.D.R. collected the samples, and filled in the dataset; P.M. and S.A. analysed the samples. F.F. wrote the first draft and handled subsequent versions of the manuscript. M.S. and C.A. wrote and supervised the writing about PK\/PD concepts. A.D.S. performed the statistical analysis. Y.L and C.Z. performed data management and edited the language. C.Z. generated tables and figures. C.R., M.T., G.G. and V.S. reviewed the manuscript. All authors approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}